抑制肠上皮细胞O型糖链的合成减少细菌的粘附及其MUC2表达
[Abstract]:Background and objective: the gut is unique in the body and has been colonized by a large number of microorganisms, especially bacteria. As the key medium of host-bacteria interaction, mucus is an important barrier between lumen microbes and underlying immune cells. Intestinal mucus is mainly composed of mucin 2 (MUC2), an important member of mucin family. Lack of Muc2 in mice leads to mucous layer deficiency in colon, but does not restrict bacterial adhesion to mucous tissue, which may lead to severe spontaneous colitis and colorectal cancer in mice. As the main component of mucin, polymer mass O-ligand glycoprotein is widely expressed in various parts of human body and plays many important roles in physiological and pathological processes. Mucin type O-glycans mainly contains four different types of Core1,Core2,Core3 and Core4. Core1O-glycans is the main O-glycans and expressed in most tissues. The absence of Core1O-glycans seriously damaged the formation of mucus layer and induced spontaneous intestinal inflammation in mice. However, it is unclear how O-glycans promotes the integrity of mucus barrier and maintains the homeostasis of intestinal environment by interacting with intestinal flora. In this study, benzyl- 伪 -galactosamine (benzyl- 伪 -GalNAc) was used to treat HT-29 of colon cancer epithelial cells and differentiated HT-29-Gal, cells to observe (enterohemorrhagicEscherichia coli serotvpe O157:H7or EHEC O157:H7 and (enteropathogenic Escherichia coli or EPEC) of enterogenic Escherichia coli. The change of cell adhesion behavior; The RNA interference of Core1 synthase (C1GALT1) was carried out on HT-29 cells and a stable transfected cell line was established to create necessary conditions for further observation of the adhesion of intestinal epithelial cells inhibited by Core1 synthase to bacteria. By studying the interaction between O-glycans and pathogenic microorganisms on mucin molecules, we can understand the pathogenesis of inflammatory bowel disease (IBD), which has a growing prevalence. Methods: 1. HT-29 of colon cancer epithelial cells was induced by galactose to obtain differentiated cells HT-29-Gal. 2. HT-29 and HT-29-Gal cells were treated with benzyl- 伪 -GalNAc. 3. The expression of MUC2 in HT-29-Gal and benzyl- 伪 -GalNAc treated with HT-29-Gal and benzyl- 伪 -GalNAc was detected by Western blot and Real-time PCR methods. 4. Four kinds of cells of HT-29,HT-29-Gal,HT-29-OBN and HT-29-Gal-OBN were co-cultured with Escherichia coli EHEC O157:H7 and EPEC, respectively. A series of dilution colony counting and immunofluorescence staining methods were used to observe the adhesion of bacteria to the above four cell surfaces. 5. 5. The interfering plasmid of Core1 synthase (C1GALT1) was constructed and transfected into HT-29 cells with high expression of Core1 synthase and screened by G418. Results: 1. The results of Western blot and Real-time PCR showed that the expression of MUC2 protein and mRNA in HT-29-OBN and HT-29-Gal-OBN cells treated with benzyl- 伪 -GalNAc was significantly lower than that in HT-29 and HT-29-Gal cells. The adhesion of HT-29-Gal-OBN and HT-29-OBN cells to Escherichia coli EHEC O157:H7 or EPEC was significantly lower than that of corresponding HT-29-Gal and HT-29 cells. Stable transfected C1GALT1 silenced HT-29 cells were obtained. Conclusion: inhibiting the synthesis of O-type sugar chain in intestinal epithelial cells and reducing the expression of MUC2 and the adhesion of bacteria.
【学位授予单位】:第三军医大学
【学位级别】:硕士
【学位授予年份】:2014
【分类号】:R574
【共引文献】
相关期刊论文 前10条
1 王培培;于广利;焦广玲;赵峡;李静;柴文刚;;基于MALDI-TOF质谱技术分析人宫颈癌HeLa细胞N-糖链结构轮廓[J];高等学校化学学报;2012年06期
2 叶钧;宋丽丽;刘韵;田音;潘琼;彭志红;汪荣泉;;肠分化细胞黏蛋白O-型糖链合成抑制导致MUC2表达减低以及对细菌侵袭易感[J];第三军医大学学报;2013年19期
3 刘韵;叶钧;宋丽丽;田音;潘琼;彭志红;汪荣泉;;Core 2和Core 4 O-型糖链参与大肠杆菌对肠上皮细胞的黏附与侵袭[J];第三军医大学学报;2014年02期
4 庄则豪,王立东,高珊珊,范宗民,宋子博,齐义军,李燕杰,李吉学;河南食管癌高发区食管和贲门癌组织中粘蛋白1的表达[J];郑州大学学报(医学版);2002年06期
5 向松涛,周四维;粘蛋白在膀胱癌诊断和治疗中应用的研究进展[J];临床泌尿外科杂志;2002年03期
6 周兵,李家邦,戴幸平;黏蛋白与胃黏膜屏障[J];临床消化病杂志;2005年03期
7 向松涛,周四维,管维,王勤章,张保,刘继红,叶章群;肿瘤浸润性树突状细胞与粘蛋白MUC1在前列腺癌与前列腺增生中的表达研究[J];中华男科学;2003年07期
8 宋丽丽;叶钧;刘韵;潘琼;钟小莉;李姗姗;田音;彭志红;汪荣泉;;O型糖链合成阻滞对肠上皮细胞MUC2表达及细菌黏附的抑制作用[J];解放军医学杂志;2013年10期
9 向松涛;周四维;管维;张旭;刘继红;庄乾元;叶章群;;糖蛋白(MUC1与MUC7)基因在膀胱移行细胞癌的表达研究[J];中华实验外科杂志;2006年02期
10 Yoshinori Inagaki;Norihiro Kokudo;Yasuji Seyama;Munehiro Nakata;Hiroshi Imamura;Keiji Sano;Yasuhiko Sugawara;Masatoshi Makuuchi;;KL-6 mucin expression in carcinoma of the ampulla of Vater: Association with cancer progression[J];World Journal of Gastroenterology;2005年35期
相关博士学位论文 前5条
1 王光海;FADD基因遗传多态与子宫颈癌易感性[D];中国协和医科大学;2009年
2 陈焰;大鼠化学诱导性结肠炎模型的建立及云母干预治疗机制探讨[D];浙江大学;2008年
3 许焕丽;“KL-6 mucin”在消化系统肿瘤中的表达、临床意义及机制研究[D];山东大学;2010年
4 王培培;动物组织中微量糖链结构分析方法的建立及应用[D];中国海洋大学;2012年
5 章文明;仔猪源高粘附性乳酸杆菌的分离鉴定、肠道定植及其粘附相关表面蛋白功能分析[D];浙江大学;2014年
相关硕士学位论文 前10条
1 刘玉霞;MUC2和CD24蛋白在卵巢上皮性癌组织中的表达及其意义[D];郑州大学;2010年
2 储玮;肝癌患者和健康人血清中甘露糖结合蛋白的分离纯化与鉴定[D];西北大学;2011年
3 李姝;Cdx2和MUC2在反流性食管炎、Barrett食管和食管腺癌中的表达[D];天津医科大学;2005年
4 张君华;ST3GalV(GM3合成酶)与肿瘤转移的关系的研究[D];中国海洋大学;2006年
5 葛宇清;O-GlcNAc糖基转移酶对小鼠乳腺癌细胞迁移的影响[D];中国海洋大学;2007年
6 刘晨;基于基因芯片技术的肝癌糖类相关基因表达谱研究[D];西北大学;2009年
7 李飞;甘草甜素对人膀胱癌细胞T24的抑制作用及其机制研究[D];河北医科大学;2010年
8 陈建平;β-1,4-半乳糖基转移酶-Ⅰ在大鼠中枢神经系统炎症反应中的表达及意义[D];南通大学;2009年
9 董婷婷;降解草酸益生菌的筛选及其对实验动物的功效研究[D];大连医科大学;2012年
10 朱影;ST6Gal-I通过上调整合素β1的唾液酸化促进绒毛膜癌细胞的迁移[D];重庆医科大学;2013年
本文编号:2228599
本文链接:https://www.wllwen.com/yixuelunwen/xiaohjib/2228599.html